205th ENMC International Workshop: Pathology diagnosis of idiopathic inflammatory myopathies Part II 28–30 March 2014, Naarden, The Netherlands
暂无分享,去创建一个
A. Mammen | F. Mastaglia | E. Aronica | H. Goebel | I. Nishino | J. Holton | W. Stenzel | E. Rushing | I. Lundberg | A. Amato | R. Gherardi | O. Benveniste | M. Dimachkie | D. Hilton‐Jones | D. Selcen | M. Visser | H. Schrøder | B. Paepe | J. Bleecker | O. D. Boer | Jan L. De Bleecker | Jan De Bleecker | J. D. Bleecker
[1] P. Chinnery,et al. Evaluation and Treatment of Myopathies , 2015, European Journal of Human Genetics.
[2] David Hilton-Jones,et al. A retrospective cohort study identifying the principal pathological features useful in the diagnosis of inclusion body myositis , 2014, BMJ Open.
[3] M. Rose,et al. International Workshop : Inclusion Body Myositis , 2 – 4 December 2011 , Naarden , The Netherlands , 2013 .
[4] I. Lundberg,et al. 193rd ENMC International workshop Pathology diagnosis of idiopathic inflammatory myopathies 30 November – 2 December 2012, Naarden, The Netherlands , 2013, Neuromuscular Disorders.
[5] David Hilton-Jones,et al. Clinical assessment determines the diagnosis of inclusion body myositis independently of pathological features , 2013, Journal of Neurology, Neurosurgery & Psychiatry.
[6] Hanno Steen,et al. Cytosolic 5′‐nucleotidase 1A autoimmunity in sporadic inclusion body myositis , 2013, Annals of neurology.
[7] B. Engelen,et al. Autoantibodies to cytosolic 5′‐nucleotidase 1A in inclusion body myositis , 2013, Annals of neurology.
[8] W. Engel,et al. Pathogenic Considerations in Sporadic Inclusion-Body Myositis, a Degenerative Muscle Disease Associated With Aging and Abnormalities of Myoproteostasis , 2012, Journal of neuropathology and experimental neurology.
[9] A. Pestronk. Acquired immune and inflammatory myopathies: pathologic classification , 2011, Current opinion in rheumatology.
[10] David Hilton-Jones,et al. Long-term observational study of sporadic inclusion body myositis. , 2011, Brain : a journal of neurology.
[11] J. Verschuuren,et al. A 12-year follow-up in sporadic inclusion body myositis: an end stage with major disabilities. , 2011, Brain : a journal of neurology.
[12] T. Maisonobe,et al. Diagnostic value of markers of muscle degeneration in sporadic inclusion body myositis , 2011, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.
[13] D. Hilton‐Jones. Observations on the classification of the inflammatory myopathies. , 2011, Presse medicale.
[14] David Hilton-Jones,et al. International Workshop on Inclusion Body Myositis held at the Institute of Myology, Paris, on 29 May 2009 , 2010, Neuromuscular Disorders.
[15] Andrew G Engel,et al. Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM , 2008, Neurology.
[16] S. Marie,et al. International consensus on a proposed score system for muscle biopsy evaluation in patients with juvenile dermatomyositis: a tool for potential use in clinical trials. , 2007, Arthritis and rheumatism.
[17] A. Pestronk,et al. Polymyositis: An overdiagnosed entity , 2004, Neurology.
[18] R. Hughes,et al. 119th ENMC international workshop: Trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, The Netherlands , 2004, Neuromuscular Disorders.
[19] W. V. van Venrooij,et al. Polymyositis , 2003, Neurology.
[20] J. C. Houwelingen,et al. Inclusion body myositis , 1998, Journal of Neurology.
[21] A. Eisen,et al. Inclusion body myositis , 1978, Neurology.
[22] A. Bohan,et al. Polymyositis and dermatomyositis (second of two parts). , 1975, The New England journal of medicine.
[23] A. Bohan,et al. Polymyositis and dermatomyositis (second of two parts). , 1975 .
[24] S. Charman,et al. clinical severity of disease dermatomyositis and association with of histological severity in juvenile Validation of a score tool for measurement , 2013 .
[25] C. Mazia. A 12-year follow-up in sporadic inclusion body myositis: an end stage with major disabilities , 2012 .
[26] Emery. Diagnostic Criteria for Neuromuscular Disorders , 1997 .
[27] Robert G. Cooper,et al. Polymyositis and Dermatomyositis , 2022 .